Tanja Obradovic: Absolutely great meeting and productive exchange around trends and needs in today’s pharma world
Tanja Obradovic, Vice President of Oncology Scientific Affairs at shared a post by Why Summits on LinkedIn and added:
“Absolutely great meeting and productive exchange around trends and needs in today’s Pharma world. Glad to hear points from Biotech, Mid-Pharma, and Large Pharma attendees on novel program and portfolio successful approaches as well as challenges. Superb organization and focus.”
Quoting Why Summits’ post:
“Tanja Obradovic, an Oncology Medical Strategy Expert, shared insightful perspectives at our conference in Philadelphia!
Participants explored successful medical affairs strategies, including Phase III clinical development, regulatory pathways, medical communication, and market access needs.
It was an informative session!”
Source: Tanja Obradovic/LinkedIn and Why Summits/LinkedIn